Literature DB >> 11641535

An experimental model of ischemia in rabbit hindlimb.

J H Hong1, Y W Bahk, J S Suh, B K Kwak, H J Shim, J S Kim, H S Kim, Y H Moon, S J Kim, J W Chung, J H Park.   

Abstract

This study was performed to establish an experimental model of ischemia for the investigation of new treatment modality of limb-threatening ischemia. We produced ischemia in the hindlimbs of 8 New Zealand white rabbits. Under general anesthesia, the left femoral artery was exposed, freed, and excised from distal external iliac artery to proximal popliteal and saphenous arteries. And then both hindlimbs were serially examined to assess the ischemia according to the time table until postoperative 6 weeks. We assessed clinical observation, blood pressure, radioisotopic perfusion scan, and angiography. Clinical ischemic changes of the operated feet were observed in 63%. The blood pressure of left calves was measurable on postoperative day 3 (p<0.05, vs preoperative day 2) and then gradually increased to reach a plateau in postoperative week 6. Radioisotopic arterial perfusion showed similar profiles as in blood pressure. Angiography of ischemic hindlimbs demonstrated a few collateral vessels arising from the internal iliac artery with the reconstitution of the posterior tibial artery in postoperative week 2. In postoperative week 6, collaterals remained the same in number. However, these became dilated and tortuous and showed reconstitution in distal hindleg. In conclusion, this is a reproducible, measurable, and economical animal model of hind limb ischemia.

Entities:  

Mesh:

Year:  2001        PMID: 11641535      PMCID: PMC3057593          DOI: 10.3346/jkms.2001.16.5.630

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


  1 in total

1.  A novel angiographic methodology for the quantification of angiogenesis.

Authors:  Matthew J Gounis; Baruch B Lieber; Keith A Webster; Ajay K Wakhloo
Journal:  IEEE Trans Biomed Eng       Date:  2008-03       Impact factor: 4.538

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.